SPIA
NVAX icon

Steward Partners Investment Advisory’s Novavax NVAX Stock Holding History

Steward Partners Investment Advisory’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.05K Hold
430
– – ﹤0.01% 4044
2026
Q1 		$3.5K Hold
430
– – ﹤0.01% 3903
2025
Q4 		$2.89K Hold
430
– – ﹤0.01% 3862
2025
Q3 		$3.73K Sell
430
-100
-19% -$778 ﹤0.01% 3745
2025
Q2 		$3.34K Hold
530
– – ﹤0.01% 3600
2025
Q1 		$3.4K Sell
530
-89
-14% -$736 ﹤0.01% 3497
2024
Q4 		$4.98K Sell
619
-285
-32% -$2.75K ﹤0.01% 3366
2024
Q3 		$11.4K Sell
904
-330
-27% -$4.26K ﹤0.01% 2902
2024
Q2 		$15.6K Sell
1,234
-66
-5% -$664 ﹤0.01% 2619
2024
Q1 		$6.21K Hold
1,300
– – ﹤0.01% 2977
2023
Q4 		$6.24K Buy
1,300
+210
+19% +$1.28K ﹤0.01% 2881
2023
Q3 		$7.89K Hold
1,090
– – ﹤0.01% 2676
2023
Q2 		$8.1K Buy
1,090
+225
+26% +$1.77K ﹤0.01% 2640
2023
Q1 		$5.99K Buy
865
+193
+29% +$1.78K ﹤0.01% 2724
2022
Q4 		$6.91K Sell
672
-272
-29% -$4.8K ﹤0.01% 2658
2022
Q3 		$17K Sell
944
-131
-12% -$5.68K ﹤0.01% 2294
2022
Q2 		$55K Sell
1,075
-277
-20% -$14.3K ﹤0.01% 1760
2022
Q1 		$100K Buy
1,352
+121
+10% +$10.8K ﹤0.01% 1611
2021
Q4 		$176K Sell
1,231
-1,098
-47% -$189K ﹤0.01% 1366
2021
Q3 		$483K Buy
2,329
+1,023
+78% +$225K 0.01% 922
2021
Q2 		$277K Sell
1,306
-5,389
-80% -$987K ﹤0.01% 1243
2021
Q1 		$1.21M Buy
6,695
+4,580
+217% +$913K 0.02% 579
2020
Q4 		$236K Buy
2,115
+1,512
+251% +$161K 0.01% 1002
2020
Q3 		$65K Buy
603
+208
+53% +$25.3K ﹤0.01% 1386
2020
Q2 		$33K Buy
395
+300
+316% +$11.5K ﹤0.01% 1584
2020
Q1 		$1K Sell
95
-50
-34% -$423 ﹤0.01% 2407
2019
Q4 		$0 Hold
145
– – ﹤0.01% 2692
2019
Q3 		$0 Sell
145
-250
-63% -$1.37K ﹤0.01% 2716
2019
Q2 		$2K Buy
+395
New +$3.11K ﹤0.01% 2448
2018
Q4 		– Sell
-395
Closed -$15K – 1677
2018
Q3 		$15K Buy
+395
New +$11.1K ﹤0.01% 1702

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Steward Partners Investment Advisory's NVAX Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Novavax (NVAX) position steady in Q2 2026 at 430 shares worth $4.05K. The position accounts for ﹤0.01% of the portfolio, ranked #4044.

Steward Partners Investment Advisory first reported a position in NVAX in Q3 2018 and has held it in 30 quarters since. The position peaked at $1.21M in Q1 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Steward Partners Investment Advisory held 430 shares of Novavax worth $4.05K as of Q2 2026.
  • Steward Partners Investment Advisory left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4044 holding.
  • Steward Partners Investment Advisory first reported a position in Novavax in Q3 2018 and has held it in 30 quarters since.
  • Steward Partners Investment Advisory's Novavax position peaked at $1.21M in Q1 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.